Rd. Brook et al., Usefulness of visceral obesity (waist/hip ratio) in predicting vascular endothelial function in healthy overweight adults, AM J CARD, 88(11), 2001, pp. 1264-1269
Citations number
29
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Vascular endothelial dysfunction (VED) is associated with obesity; however,
its etiology remains controversial. By determining the predictors of fasti
ng and postprandial endothelial function in overweight adults without other
cardiovascular risk factors, we were able to investigate novel mechanisms
directly linking obesity to VIED. Thirty-two healthy adults (body mass inde
x [BMI] greater than or equal to 27 kg/m(2)) underwent determination of fas
ting low-density lipoprotein (LDL) particle size, high sensitivity C-reacti
ve protein levels, anthropometric measurements, and endothelial function by
flow-mediated dilation (FMD) of the brachial artery. Postprandial lipemia
and FMD were measured 4 hours after ingestion of a high-fat meal. Blood pre
ssures and fasting levels of lipoproteins, glucose, insulin, and fatty acid
s were within normal limits in all subjects. An abdominal fat pattern, as d
etermined by an increased waist/hip ratio (WHIZ), was the sole significant
predictor of FMD (r = -0.58, p = 0.001), despite no significant correlation
between whole body obesity (BMI) and FMD. At comparable levels of BMI, obe
se subjects with a WHR greater than or equal to0.85 had a significantly blu
nted FMD compared with those with a WHR <0.85 (3.93 +/- 2.85% vs 8.34 +/- 5
.47%, p = 0.016). Traditional coronary risk factors, C-reactive protein, po
stprandial lipemia, and LDL particle size did not predict FMD. We found no
appreciable alteration in the postprandial state from fasting FMD (6.31 +/-
4.62% vs 6.25 +/- 5.47%, p = 0.95). The same results were found when women
were analyzed alone. Increased abdominal adiposity determined by a simple
WHR is a strong independent predictor of VED even in healthy overweight adu
lts; this is a finding unexplained by alterations in conventional risk fact
ors, systemic inflammation, or the atherogenic lipoprotein pattern. (C) 200
1 by Excerpta Medica, Inc.